SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-012713
Filing Date
2020-11-05
Accepted
2020-11-05 07:42:50
Documents
97
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20200930x10q.htm   iXBRL 10-Q 2188525
2 EX-10.1 tmb-20200930xex10d1.htm EX-10.1 599337
3 EX-10.2 tmb-20200930xex10d2.htm EX-10.2 17231
4 EX-31.1 tmb-20200930xex31d1.htm EX-31.1 10562
5 EX-31.2 tmb-20200930xex31d2.htm EX-31.2 10616
6 EX-32.1 tmb-20200930xex32d1.htm EX-32.1 7963
7 GRAPHIC tmb-20200930xex10d2001.jpg GRAPHIC 13569
  Complete submission text file 0001558370-20-012713.txt   10493319

Data Files

Seq Description Document Type Size
8 EX-101.SCH tmb-20200930.xsd EX-101.SCH 88364
9 EX-101.CAL tmb-20200930_cal.xml EX-101.CAL 59394
10 EX-101.DEF tmb-20200930_def.xml EX-101.DEF 360182
11 EX-101.LAB tmb-20200930_lab.xml EX-101.LAB 574168
12 EX-101.PRE tmb-20200930_pre.xml EX-101.PRE 596489
13 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20200930x10q_htm.xml XML 1630011
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14710 | Film No.: 201288724
SIC: 2834 Pharmaceutical Preparations